Baclofen (Intrathecal)
Abrupt Discontinuation
- Abrupt discontinuation has resulted in high fever, altered mental status, exaggerated rebound spasticity, and muscle rigidity that in rare cases advances to rhabdomyolysis, multiple organ system failure and death.
- Careful attention to proper programming and monitoring of infusion system, refill schedules and procedures, and pump alarms to avoid abrupt withdrawal
- Patients and caregivers should be advised of the importance of keeping scheduled refill visits and should be
educated on the early symptoms of baclofen withdrawal - Special attention should be given to patients at apparent risk(e.g. spinal cord injuries at T-6 or above, communication difficulties, history of withdrawal symptoms from oral or intrathecal baclofen).
- Consult the technical manual of the implantable infusion system for additional post implant clinician and patient information.
Monitoring data
- Careful attention to proper programming and monitoring of infusion system, refill schedules and procedures, and pump alarms to avoid abrupt withdrawal
- Advise patient and caregivers of compliance importance
- Black box data added April 2002
- Special attention should be given to patients at apparent risk(e.g. spinal cord injuries at T-6 or above, communication difficulties, history of withdrawal symptoms from oral or intrathecal baclofen).
- Consult the technical manual of the implantable infusion system for additional post implant clinician and patient information.
Patient counseling
Package inserts
Additional information
Updated: January 2018